Country: কানাডা
ভাষা: ইংরেজি
সূত্র: Health Canada
DESLORATADINE
APOTEX INC
R06AX27
DESLORATADINE
5MG
TABLET
DESLORATADINE 5MG
ORAL
10/12/20/24/30/36/48/50
OTC
SECOND GENERATION ANTIHISTAMINES
Active ingredient group (AIG) number: 0143961001; AHFS:
APPROVED
2010-02-05
Page 1 of 35 PRODUCT MONOGRAPH DESLORATADINE TABLETS 5 MG DESLORATADINE HISTAMINE H 1 -RECEPTOR ANTAGONIST APOTEX INC. DATE OF REVISION: 150 SIGNET DRIVE OCTOBER 17, 2018 TORONTO, ONTARIO M9L 1T9 CONTROL NUMBER: 220366 Page 2 of 35 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ........................................................ 3 SUMMARY PRODUCT INFORMATION ................................................................................ 3 INDICATIONS AND CLINICAL USE ...................................................................................... 3 CONTRAINDICATIONS ........................................................................................................... 3 WARNINGS AND PRECAUTIONS .......................................................................................... 3 ADVERSE REACTIONS ........................................................................................................... 5 DRUG INTERACTIONS ............................................................................................................ 6 DOSAGE AND ADMINISTRATION ........................................................................................ 7 OVERDOSAGE .......................................................................................................................... 7 ACTION AND CLINICAL PHARMACOLOGY ....................................................................... 7 STORAGE AND STABILITY .................................................................................................. 10 SPECIAL HANDLING INSTRUCTIONS ............................................................................... 10 DOSAGE FORMS, COMPOSITION AND PACKAGING ...................................................... 10 PART II: SCIENTIFIC INFORMATION ............................................................................... 12 PHARMACEUTICAL INFORMATION ................................................................................. 12 CLINICAL TRIALS ............................. সম্পূর্ণ নথি পড়ুন